ArticleFrontiers in immunology2020

Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells.

Chen Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.